公司資料
Immunic 股價、新聞與催化劑
- 股票代碼:
- IMUX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Germany
股票表現
16.46 USD (-0.24%)
收盤價
最後更新: 2026年8月24日
199M USD
市值
股價為何變動
As of Aug 24, 2026, IMUX was little changed and closed at $16.46. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Immunic is a biotechnology company focused on immune-mediated disease and small-molecule immunology. Its pipeline is aimed at inflammatory and autoimmune disorders.
所在地與產業分類
Headquartered in Germany and listed on NASDAQ as an ADR, Immunic has a global specialty-biopharma profile.
商業模式特徵
The company depends on clinical data, target validation, and the ability to create a differentiated inflammation franchise.
生技產業定位
Immunic is a catalyst-sensitive immunology name whose stock reacts to early clinical and mechanistic signals.
未來催化劑
- Immunic’s catalysts are vidofludimus calcium and the autoimmune / neuroinflammation pipeline, where each update can change the company’s credibility quickly. The market still needs a stronger human-data story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。